5 year survival for childhood and adolescent cancer in developed countries is now in excess of 80% and the number of survivors of cancer continues to increase worldwide. After completion of therapy, many of these survivors will face a lifelong risk of endocrine late effects.

Authors: Emily S Tonorezos, Prof Melissa M Hudson, Angela B Edgar, Leontien C Kremer, Prof Charles A Sklar, Prof W Hamish B Wallace, Prof Kevin C Oeffinger

Read more